IRIS UniCatt

Autore, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.100
AS - Asia 2.903
EU - Europa 2.304
SA - Sud America 759
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
Totale 9.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.015
SG - Singapore 1.347
CN - Cina 809
BR - Brasile 614
IT - Italia 495
SE - Svezia 491
DE - Germania 311
FR - Francia 200
VN - Vietnam 184
GB - Regno Unito 152
IE - Irlanda 149
IN - India 129
ID - Indonesia 115
UA - Ucraina 101
FI - Finlandia 99
RU - Federazione Russa 91
PL - Polonia 68
AR - Argentina 57
BD - Bangladesh 46
CA - Canada 42
TR - Turchia 39
JP - Giappone 34
HK - Hong Kong 33
KR - Corea 33
EC - Ecuador 30
IQ - Iraq 30
MX - Messico 30
CI - Costa d'Avorio 25
AT - Austria 24
ZA - Sudafrica 21
ES - Italia 19
CO - Colombia 18
BE - Belgio 17
CZ - Repubblica Ceca 16
NL - Olanda 16
MA - Marocco 12
PY - Paraguay 12
VE - Venezuela 11
IR - Iran 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
CH - Svizzera 8
EG - Egitto 8
IL - Israele 8
KE - Kenya 7
NP - Nepal 7
PK - Pakistan 7
TN - Tunisia 7
CL - Cile 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
KZ - Kazakistan 5
DZ - Algeria 4
GR - Grecia 4
JO - Giordania 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
CY - Cipro 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
LT - Lituania 3
NO - Norvegia 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
RS - Serbia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GA - Gabon 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
Totale 9.154
Salva come PNG Salva come JPEG
Città #
Singapore 586
Chandler 503
Ashburn 278
Beijing 215
Dublin 144
Rome 130
Jakarta 102
Los Angeles 99
Hefei 98
Wilmington 84
Jacksonville 81
Dearborn 76
Ann Arbor 75
Florence 75
San Mateo 75
Nanjing 73
Munich 70
Cattolica 69
Hyderabad 69
Lancaster 69
Ho Chi Minh City 67
New York 66
Warsaw 63
Boston 60
Frankfurt am Main 60
Dallas 58
Milan 55
Chicago 53
Princeton 51
Fairfield 46
Woodbridge 46
São Paulo 43
Moscow 39
Hanoi 38
Marseille 38
Nanchang 37
Buffalo 36
Seattle 36
Houston 35
Seoul 32
Helsinki 31
Hong Kong 30
Bremen 27
Kent 26
Abidjan 25
Lawrence 25
Redwood City 25
The Dalles 25
Turku 24
Brooklyn 22
Tokyo 22
Cambridge 21
Kunming 21
Rio de Janeiro 21
Stockholm 21
Lappeenranta 19
Izmir 18
Tianjin 18
Auburn Hills 17
Brussels 17
Nuremberg 17
Redmond 17
Boardman 16
Santa Clara 16
Washington 16
Pune 15
Shenyang 15
Naples 14
Phoenix 14
Salt Lake City 14
Atlanta 13
Campinas 13
Düsseldorf 12
London 12
Norwalk 12
Porto Alegre 12
Tampa 12
Toronto 12
Vienna 12
Hangzhou 11
Johannesburg 11
Montreal 11
Mountain View 11
Baghdad 10
Denver 10
Dhaka 10
Orem 10
Paris 10
Poplar 10
Shanghai 10
Bogotá 9
Elk Grove Village 9
Guangzhou 9
Guayaquil 9
Hebei 9
Kyoto 9
Lauterbourg 9
San Francisco 9
Tashkent 9
Biên Hòa 8
Totale 4.852
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 316
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 166
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 142
Role of microRNAs in Chronic Lymphocytic Leukemia 140
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 135
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 135
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 132
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 125
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 124
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 121
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 117
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 115
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 113
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 110
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 109
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 107
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 104
Unrelated cord blood transplantation and post-transplant cyclophosphamide 104
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 101
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 100
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 100
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 99
the concomitance of lymphoma and breast carcinoma in the bone 99
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 97
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 96
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 96
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 96
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 95
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 94
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 94
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 93
Second haploidentical stem cell transplantation for primary graft failure 93
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 92
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 90
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 90
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 88
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 88
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 88
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 86
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 86
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 84
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 84
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 84
Unrelated cord blood transplantation and post-transplant cyclophosphamide 84
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 83
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 83
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 83
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 83
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 82
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 82
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 81
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 81
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 80
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 80
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 80
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 80
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 80
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 78
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 78
Richter transformation in Chronic Lymphocytic Leukemia 77
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation 77
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 77
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 77
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 77
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 76
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 75
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 74
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. 73
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 73
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 73
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 72
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 71
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 71
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 71
The concomitance of lymphoma and breast carcinoma in the bone 71
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review 70
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 69
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. 69
Second haploidentical stem cell transplantation for primary graft failure 68
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 68
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 67
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience 67
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia 65
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 64
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 64
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 63
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 63
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 62
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 62
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 61
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 61
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 61
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 61
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 61
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 60
'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy 60
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 60
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia 59
New developments in the management of chronic lymphocytic leukemia: Role of ofatumumab 58
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 57
Totale 8.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021170 0 0 0 0 0 29 15 5 33 13 62 13
2021/2022589 51 15 22 24 50 5 7 88 31 33 135 128
2022/20231.442 199 187 106 199 103 193 80 91 165 34 64 21
2023/2024892 39 221 65 77 38 133 65 22 16 34 82 100
2024/20252.000 51 61 135 70 148 60 67 74 226 214 547 347
2025/20262.813 704 190 344 634 725 216 0 0 0 0 0 0
Totale 9.344